1. CYP2C9 and OATP1B1 genetic polymorphisms affect the metabolism and transport of glimepiride and gliclazide
    Fayou Yang et al, 2018, Scientific Reports CrossRef
  2. Functional Proliferating Human Hepatocytes: In Vitro Hepatocyte Model for Drug Metabolism, Excretion, and Toxicity
    Shida Qiao et al, 2021, Drug Metabolism and Disposition CrossRef
  3. Pharmacogenetics of Drugs Used in the Treatment of Cancers
    Beata Franczyk et al, 2022, Genes CrossRef
  4. Genetic Contributions to Maternal and Neonatal Vitamin D Levels
    Michela Traglia et al, 2020, Genetics CrossRef
  5. Recent advances in the personalized treatment of estrogen receptor-positive breast cancer with tamoxifen: a focus on pharmacogenomics
    Ondřej Slanař et al, 2021, Expert Opinion on Drug Metabolism & Toxicology CrossRef
  6. Impact of organic anion transporting polypeptide, P-glycoprotein, and breast cancer resistance protein transporters on observed tamoxifen and endoxifen concentration and adverse effects
    Denise N. Keller et al, 2023, Pharmacogenetics and Genomics CrossRef
  7. Unraveling ‘The Cancer Genome Atlas’ information on the role of SLC transporters in anticancer drug uptake
    Ruba Al-Abdulla et al, 2019, Expert Review of Clinical Pharmacology CrossRef
  8. Effect of Genetic Variability in 20 Pharmacogenes on Concentrations of Tamoxifen and Its Metabolites
    Yuanhuang Chen et al, 2021, Journal of Personalized Medicine CrossRef
  9. Effects of the SLCO1B1 A388G single nucleotide polymorphism on the development, clinical parameters, treatment, and survival of multiple myeloma cases in a Polish population
    Katarzyna Michalska et al, 2023, Molecular Biology Reports CrossRef
  10. Quantitative Proteomics in Translational Absorption, Distribution, Metabolism, and Excretion and Precision Medicine
    Deepak Ahire et al, 2022, Pharmacological Reviews CrossRef
  11. Pharmacological Inhibition of MCT4 Reduces 4-Hydroxytamoxifen Sensitivity by Increasing HIF-1α Protein Expression in ER-Positive MCF-7 Breast Cancer Cells
    Takanobu Nadai et al, 2021, Biological and Pharmaceutical Bulletin CrossRef
  12. The Role of Solute Carrier Transporters in Efficient Anticancer Drug Delivery and Therapy
    Elena Puris et al, 2023, Pharmaceutics CrossRef
  13. Identification of anticancer OATP2B1 substrates by an in vitro triple-fluorescence-based cytotoxicity screen
    Tímea Windt et al, 2019, Archives of Toxicology CrossRef
  14. The role of OATP1B1 and OATP1B3 transporter polymorphisms in drug disposition and response to anticancer drugs: a review of the recent literature
    Nadeen Anabtawi et al, 2022, Expert Opinion on Drug Metabolism & Toxicology CrossRef
  15. Research progress in the application of bile acid-drug conjugates: A “trojan horse” strategy
    Kelu Lei et al, 2021, Steroids CrossRef